HL5 Stock Chart & Stats
€18.00
€0.00(0.00%)
At close: 4:00 PM EST
€18.00
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€16.60 - €25.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€716.94M
Enterprise Value€724.95M
Total Cash (Recent Filing)€66.50M
Total Debt (Recent Filing)€14.07M
Price to Earnings (P/E)42.1
Beta<0.01
Next Earnings
Jul 27, 2026EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.67
Shares Outstanding29,215,187
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-4.99
Price to Book (P/B)1.96
Price to Sales (P/S)2.28
P/FCF Ratio11.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€28.00Price Target Upside55.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4
EPS Forecast (FY)0.63
Revenue Forecast (FY)€281.05M
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetVery low leverage and a strong cash position provide durable financial flexibility. With virtually no long-term debt and an untapped credit line, the company can fund acquisitions, R&D, buybacks, or weather downturns without forcing dilutive financing, preserving strategic optionality over 2–6 months.
Recurring Revenue And RPO VisibilityA subscription-centric model with $687M RPO gives durable revenue visibility and high renewal potential. Contracted flows backing near-term revenue conversion reduce execution risk and support predictable cash generation as customers continue workforce tech consumption.
Strong Cash Generation And Healthy MarginsHigh-quality operating cash flow and robust gross/EBITDA margins indicate durable profitability and free-cash generation. Cash conversion close to net income supports reinvestment, capital returns, and margin resilience versus peers over the medium term.
Bears Say
Legacy Product Migration DragDeclines in legacy credentialing/scheduling revenue reflect migration-related churn that can pressure near-term top-line growth. Migrating long-term customers is strategic but creates temporary revenue gaps and prolongs the pace at which new solution adoption fully offsets attrition.
Planned Investments And Cloud Margin RiskManagement is accelerating hiring, tech and AI investments which will raise operating spend. Separately, planned cloud migrations introduce structural gross-margin pressure. These initiatives can expand TAM long term but may meaningfully temper margin progression in the medium term.
FCF Volatility And Modest Net MarginsWhile recent cash generation is strong, historical free-cash-flow swings and sub-7% net margins signal sensitivity to operating variability and investments. This limits resilience to shocks and constrains capacity for aggressive reinvestment without impacting free cash flow.
HL5 FAQ
What was Healthstream’s price range in the past 12 months?
Healthstream lowest stock price was €16.60 and its highest was €25.00 in the past 12 months.
What is Healthstream’s market cap?
Healthstream’s market cap is €716.94M.
When is Healthstream’s upcoming earnings report date?
Healthstream’s upcoming earnings report date is Jul 27, 2026 which is in 16 days.
How were Healthstream’s earnings last quarter?
Healthstream released its earnings results on May 04, 2026. The company reported €0.175 earnings per share for the quarter, beating the consensus estimate of €0.142 by €0.033.
Is Healthstream overvalued?
According to Wall Street analysts Healthstream’s price is currently Undervalued.
Does Healthstream pay dividends?
Healthstream does not currently pay dividends.
What is Healthstream’s EPS estimate?
Healthstream’s EPS estimate is 0.15.
How many shares outstanding does Healthstream have?
Healthstream has 29,215,187 shares outstanding.
What happened to Healthstream’s price movement after its last earnings report?
Healthstream reported an EPS of €0.175 in its last earnings report, beating expectations of €0.142. Following the earnings report the stock price went up 5.718%.
Which hedge fund is a major shareholder of Healthstream?
Currently, no hedge funds are holding shares in DE:HL5
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HealthStream Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€28.00 (55.57% Upside)
€28.00 (55.57% Upside)
Blogger Sentiment
Bullish
DE:HL5 Sentiment 100%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth €63.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.66%
12-Months-Change
Fundamentals
Return on Equity
5.67%
Trailing 12-Months
Asset Growth
0.65%
Trailing 12-Months
Company Description
Healthstream
HealthStream, Inc., established in 1990 and headquartered in Nashville, Tennessee, delivers specialized workforce and provider solutions to healthcare organizations throughout the United States. Its operations are divided into two primary segments: Workforce Solutions and Provider Solutions. The Workforce Solutions segment provides a suite of software-as-a-service (SaaS) and subscription-based tools. These comprehensive services address various aspects of healthcare staff development and management, encompassing clinical skill enhancement, talent acquisition and retention, training programs, educational resources, professional certification, scheduling logistics, competency evaluations, and performance reviews. Additionally, this segment offers support through implementation and account management. Specific applications under this umbrella cover learning platforms, performance assessment, competency tracking, disclosure management, clinical skill evaluation, simulation-based learning, quality assurance, and sector-specific training. Complementing this, the Provider Solutions segment focuses on administrative and operational needs. It includes VerityStream, an enterprise platform designed to optimize the experience for healthcare providers across diverse settings such as ambulatory surgery centers, urgent care clinics, medical groups, and other facilities. Furthermore, HealthStream offers EchoCredentialing and MSOW platforms to streamline the credentialing, enrollment, and privileging processes for medical staff in hospitals. EchoOneApp facilitates provider enrollment for medical groups. Other key offerings comprise CredentialMyDoc, a SaaS solution for credentialing and enrollment for medical groups and surgery centers; CredentialStream, another SaaS-based platform for provider credentialing, privileging, and enrollment; and NurseGrid Mobile, a dedicated application for nurse managers. These diverse solutions are marketed directly to a broad spectrum of healthcare entities, including private, non-profit, and governmental organizations, as well as pharmaceutical and medical device manufacturers.
HL5 Company Deck
HL5 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call highlighted robust top-line and margin expansion (record revenue and adjusted EBITDA), strong product-level growth (CredentialStream, ShiftWizard, Competency Suite), successful acquisition integrations, a healthy balance sheet and cash generation, and reaffirmed full-year guidance. Management also outlined deliberate, accelerated investments (career networks, My Clinical Exchange infrastructure, sales hiring, and AI) which will modestly increase operating spend and may temper near-term margin cadence. Legacy product migration and potential margin pressure from cloud initiatives are the primary operational risks noted, but they are balanced against strong organic momentum and strategic investments that aim to expand addressable markets and long-term growth.View all DE:HL5 earnings summariesHL5 Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
€28.00
▲(55.57% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Evolent Health
―
Health Catalyst
―
Clinigence Holdings
―
Definitive Healthcare Corp
―
Omada Health, Inc.
―
Options Prices
Currently, No data available
---









